Twist Bioscience Ignites: A 13.41% Surge to Historic Heights Demands Attention

Summary

• Twist Bioscience (TWST) rocketed 13.41% to close at $112.785, shattering previous records.
• The stock touched a fresh 52-week high of $112.9899 during intraday trading.
• Options activity surged, with significant volume concentrated in August and September 2026 call contracts.
• Turnover reached 1,524,820 shares, signaling a massive shift in institutional and retail interest.

Twist Bioscience has executed a definitive breakout, leaving the $100 psychological barrier far behind in a display of pure momentum. The stock opened at $104.50 and climbed relentlessly to its session high, closing just 20 cents shy of its intraday peak. This aggressive expansion, backed by robust turnover, suggests a fundamental re-rating or a powerful sector-wide catalyst is driving capital into this synthetic biology leader.

Momentum Breakout Drives Twist Bioscience to Record Levels

The primary driver of this explosive move is a technical and psychological breakout above the $100 resistance level, amplified by a surge in trading volume. The stock’s ability to hold near its intraday high of $112.99 indicates strong buying pressure with minimal selling interest at these elevated levels. The 13.41% intraday gain reflects a sudden influx of capital, likely triggered by renewed investor confidence in the synthetic DNA sector or specific company-level developments not explicitly detailed in the broad sector news but strongly implied by the market's reaction. The sharp rise from the previous close of $99.445 confirms a shift from consolidation to aggressive accumulation.

Biotechnology Sector Context: Innovation Outpaces General Sentiment

While the broader Biotechnology sector news highlights diverse innovations—from sunflower-based vegan meats to AI-designed DNA controls—the movement in Twist Bioscience appears decoupled from immediate sector-wide headlines. The sector news emphasizes long-term scientific breakthroughs like T7-ORACLE protein evolution and CRISPR advancements, which underpin the long-term thesis for companies like TWST but do not directly cause short-term price spikes. However, the sector leader, Regeneron (REGN), posted a modest 2.08% gain, indicating a generally positive but subdued sector environment. TWST’s 13.41% surge significantly outperforms this average, suggesting idiosyncratic strength or specific catalysts unique to its synthetic biology platform rather than broad sector rotation.

Strategic Options Play: Leveraging Bullish Momentum with Precision

• 200-day moving average: $53.27 (Strongly Below; indicates a powerful long-term uptrend)
• 30-day moving average: $93.50 (Below Current Price; confirms short-term bullish momentum)
• RSI: 56.78 (Neutral-Bullish; room for further upside without being overbought)
• MACD: 2.38 (Above Signal Line; bullish momentum is accelerating)
• Bollinger Bands Upper: $99.67 (Price is well above; indicates an extended, strong trend)

The technical landscape is unequivocally bullish. TWST is trading significantly above all key moving averages, with the 30-day average at $93.50 providing immediate support. The RSI at 56.78 suggests the stock is not yet overextended, allowing for continued upside potential. The MACD histogram is positive, confirming that momentum is building. Aggressive bulls should look for pullbacks toward the $104–$105 range to enter long positions, while holding above $112 maintains the short-term trend integrity. For options traders, the key is to capture this momentum with defined risk.

Based on the provided options chain, we have identified two high-potential contracts that balance leverage, liquidity, and delta exposure:

• TWST20260821C115: Call Option, Strike $115, Expiration 2026-08-21. IV: 56.70%, Leverage: 24.03%, Delta: 0.47, Theta: -0.29, Gamma: 0.03, Turnover: 5,952. (IV: Moderate cost; Leverage: Balanced risk/reward; Delta: Moderate sensitivity; Theta: High time decay; Gamma: High price sensitivity; Turnover: Good liquidity)
This contract stands out for its balanced profile. With a delta near 0.50, it offers significant upside participation with less premium cost than deep ITM calls. The high gamma of 0.03 means it will benefit rapidly from price increases, and the turnover ensures easy entry and exit. It is ideal for traders expecting a continued move above $115 in the near term.

• TWST20260918C120: Call Option, Strike $120, Expiration 2026-09-18. IV: 64.11%, Leverage: 15.00%, Delta: 0.45, Theta: -0.16, Gamma: 0.02, Turnover: 15,753. (IV: Higher cost for more time; Leverage: Moderate; Delta: Moderate sensitivity; Theta: Lower time decay; Gamma: Moderate price sensitivity; Turnover: Highest liquidity in chain)
This contract offers the highest liquidity in the chain, making it ideal for larger positions. The longer expiration (September) reduces time decay pressure (theta), allowing more time for the thesis to play out. The delta of 0.45 provides a solid hedge against immediate reversals while still capturing 45% of the underlying's move.

Options Payoff Calculation Primer: For this payoff estimation, we assume a 5% upside scenario from current price (112.785) where for Call Option Payoff = max(0, ST - K) where ST is projected price and K is strike price and Put Option Payoff = max(0, K - ST) where ST is projected price and K is strike price. This projection helps evaluate option contracts' potential returns under a continued bullish move scenario.

If $115 breaks with volume, TWST20260821C115 offers aggressive upside potential with high gamma exposure.

Maintain Long Bias: TWST Shows No Signs of Slowing

The move in Twist Bioscience is sustainable as long as the stock holds above the $104 support level. The technical indicators, particularly the rising MACD and the price's position well above the 30-day moving average, confirm that buyers are in control. Investors should watch for a retest of the $113–$114 resistance zone; a breakout above this level could trigger further algorithmic buying. Keep an eye on the broader biotech sector, led by Regeneron (REGN) with its 2.08% gain, for sector-wide confirmation. Watch for $104 breakdown or a failure to hold above $113 to signal a potential short-term reversal.